This week brought compelling advances across global science and medicine. MIT neuroscientists demonstrated that acoustic stimulation using gentle pink noise during deep sleep enhances cerebrospinal fluid flow through the brain. This finding offers new therapeutic avenues for reversing age-related decline in brain waste clearance, with direct implications for Alzheimer's prevention.
In clinical oncology, the US FDA granted full approval for giredestrant, an oral selective estrogen receptor degrader (SERD) for ESR1-mutated advanced breast cancer, demonstrating a 62% reduction in disease progression risk. Simultaneously, Stanford researchers revealed that resting-state brain connectivity patterns (the ARC score) can predict Alzheimer's vulnerability years before cognitive symptoms emerge.
In space and physics, the European Space Agency's Euclid mission released its landmark initial dataset mapping over 900 million galaxies and identifying 31 primordial quasars dating back to the cosmic dawn. In India, ISRO completed a crucial ground test of its upgraded PSLV third-stage motor at Sriharikota, setting the stage for the workhorse launcher's return to flight.





